As of March 2018, our recombinant blood group antigens (rBGA) and DaraEx can be purchased from inno-train Diagnostik GmbH.

We have developed a new, patent-pending remedy for anti-CD38 antibody interference in immunohematological pre-transfusion testing, called "DaraEx".

EN ISO 13485:2016, issued July 31^th, 2018

Certificate